Mexican Chronic Renal Insufficiency Cohort Study

墨西哥慢性肾功能不全队列研究

• 批准号: 8720829
• 负责人: JAMES P. LASH
• 金额: $ 5.15万
• 依托单位: UNIVERSITY OF ILLINOIS AT CHICAGO
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-09-20 至 2017-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8720829
• 关键词: Anemia due to Chronic Disorder; Award; Blood Pressure; Bone Diseases; Cardiovascular Diseases; Cardiovascular system; Cause of Death; Chicago; Chronic Kidney Failure; Chronic Kidney Insufficiency; Cities; Clinical; Cohort Studies; Collaborations; Country; Data; Dialysis procedure; Disease Progression; Education; End stage renal failure; Enrollment; Epidemiology; Event; Extramural Activities; Funding; Future; Glucose; Goals; Health; Health Services Accessibility; Health behavior; Hispanics; Hospital Mortality; Illinois; Income; Inflammation; Institution; International; Kidney Diseases; Kidney Failure; Kidney Transplantation; Knowledge; Life; Lipids; Mental Depression; Metabolic Bone Diseases; Metabolism; Mexican; Mexico; Minerals; Mission; National Institute of Diabetes and Digestive and Kidney Diseases; Not Hispanic or Latino; Outcome; Participant; Patients; Prevalence; Principal Investigator; Proteinuria; Public Health; Public Health Schools; Quality of life; Recruitment Activity; Renal function; Research; Research Infrastructure; Research Methodology; Research Personnel; Resources; Risk Factors; Smoking; Social support; Training; United States National Institutes of Health; Universities; base; cardiovascular risk factor; cohort; design; disorder control; follow-up; functional status; health literacy; improved; patient oriented; programs; public health relevance

DESCRIPTION (provided by investigator): The proposed Mexican Chronic Renal Insufficiency Cohort Study is collaboration between a U.S. based NIH- funded investigator, James P. Lash, MD and Magdalena Madero, MD, a nephrologist at the Instituto Nacional de Cardiologia Ignacio Chavez in Mexico City. In Mexico, chronic kidney disease (CKD) represents a growing public health problem, with an increase in prevalence of 11% per year in the last 10 years. Furthermore, CKD is the third most common cause of in-hospital mortality in Mexico. Despite the magnitude of this problem, little is known about the epidemiology of CKD in Mexico. A better understanding of risk factors for progression of CKD is of critical importance because less than one-half of patients with kidney failure in Mexico have access to dialysis or kidney transplantation. The overall objective of this application is to recruit and retain a cohort of 340 Mexicans with mild-to-moderate CKD. Preliminary data generated during the period of support will be utilized to apply for extramural funding to extend participant follow-up in order to accomplish the following long- term Specific Aims: 1) Identify risk factors for progression of kidney disease in Mexicans with CKD; 2) Identify risk factors for cardiovascular events and progression of subclinical cardiovascular disease; 3) Evaluate the association between CKD and other clinical outcomes such as functional status, quality of life, and depression; and 4) Compare rates of CKD progression between Mexicans with CKD living in Mexico and Mexicans with CKD living in the U.S. The proposed study will leverage the infrastructure of an active NIDDK-funded research program which is focused on investigating the epidemiology of CKD in U.S. Hispanics and non-Hispanics (Principal Investigator Lash, R01 DK72231, and U01 DK60980) and the extensive training resources available at the University of Illinois at Chicago School of Public Health. This application fulfills the mission of the Fogarty International Research Collaboration Award program by building epidemiologic CKD research capabilities in Mexico and providing training in research methodology for Dr. Madero and other trainees at her institution. Furthermore, the knowledge gained by the research has the potential to inform the design of future interventional trials with the goal of improving health outcomes for Mexicans with CKD.

描述（由研究者提供）：拟议中的墨西哥慢性肾功能不全队列研究是由美国国立卫生研究院资助的研究者James P. Lash医学博士和墨西哥城国立Ignacio Chavez心脏病研究所的肾病学家Magdalena Madero医学博士合作进行的。在墨西哥，慢性肾脏疾病（CKD）是一个日益严重的公共卫生问题，在过去10年中，其患病率以每年11%的速度增长。此外，慢性肾病是墨西哥住院死亡的第三大常见原因。尽管这个问题很严重，但人们对墨西哥慢性肾病的流行病学知之甚少。更好地了解CKD进展的危险因素至关重要，因为在墨西哥，只有不到一半的肾衰竭患者能够接受透析或肾移植。这项申请的总目标是征聘和留住340人